Dr. B - Now we would
like to talk about the repertories in general and Synthesis in particular.
You have been associated with this project since 1983. How did it
happen that you started working on this project?
FS - At that time when everything was tiny and small, there were
only a few homeopaths, say 10 or so who were interested in the software
development and I was one of them. And so I took up the responsibility
and became the coordinator of the little group and it never ended.
Dr. B - What was the experience like
working on this project? That was the first time homeopathic software
was being made for Windows. It was a totally new path. How did you
feel trekking on it?
FS - It was sometimes very hard because I, myself, was not convinced
that technology will ever be able to help in homeopathy. In fact
at times, I was against the development of homeopathic software.
Even after I got convinced, the first years, almost 10 years, there
was lots of resistance in the homeopathic community. I was not even
allowed to speak about it in certain schools when I was teaching
my cases. People told me, don’t speak about computers. It
was perceived as commercial! Now that has changed. Now there is
no seminar in the world where people do not present the case with
computerized case analysis or computerized material medica. But
it was a very difficult time while there was a lot of animosity
during the developmental years.
Dr. B - What was it like when you released
the initial version of RADAR. What was the feedback like?
FS - First, when we printed the book, it came down to a more usable
level… because it was a book, you see, and that really made
a change because people said ...ah! This is Kent and for this rubric
I have Synthesis …it was a big difference as there were different
remedies and there were different results. So that started really
changing a lot of things.
Dr. B - Synthesis has come a long
way ...9 versions. There has been an increase in quality and quantity
at the same time. In the past, there have been allegations that
a lot of medicines and rubrics are being added which are not verified.
I know your method now, that you first create an empty repertory
with rubrics, then a second team adds the medicines and a third
team cross-checks everything. But was it like this from the very
beginning?
FS – No! Because, first I was almost alone,
with 2 other people to do all the work. Then a few more and few
more came together. The work is so enormous. We do a job and at
the same time there is a request for 2 or 3 other projects. The
repertory is absolutely not final. We need to do much more work
to streamline it, to increase the quality of the index, it has to
be done. We have now such a wide range of people using it that I
believe that we will reach that level. But it is just such a tremendous
job and a lot has not been done. When someone asks me why you have
not added the proving of blah blah blah, I reply, Because I can
only work for 48 hrs out of a 24 hour day, and because you were
not helping us!
Dr. B - Primarily, when you start
compiling a new repertory, you add remedies and rubrics from other
sources, clinical data, provings, and other repertories from works
that have already been done. How do you verify that what is written
in those sources is correct? Because in many of such works also,
the preferences and biases about various remedies and rubrics have
crept in due to the clinical experience of the author.
FS - That is a very difficult aspect of the work and we have been
doing it in the following way: When there is an author who says
that Bellis-p is good for this thing, we will add it with the reference
of the author. So people can first check whether this information
exists in a book or an article or if it is clinical information.
They can go back to this person and ask about the clinical case
and verify the information. In addition, by adding the author reference,
we are inviting you to verify. You will see that in many remedies
in Synthesis, there is not one but 4 or 5 author references. In
this way, the knowledge base is increasing and maybe in ten years,
there will be a number of remedies that have gotten confirmation
from the clinic and will have many references. However, there will
be remedies which will never get confirmed. Then it is an aspect
of confidence that remedies supported by only one source are not
very useful! So, repertory becomes like a mixture of information
which is very solid and confirmed by everybody and there is some
information which lies there with a question mark. This indication
of the references of each remedy is clear and can be used. If you
want to use Synthesis with all the confirmed rubrics, you can. When
you prescribe your 10 or 20 polychrests and you don’t get
anywhere, you say, Show me also all the hypothetical information
and you may see new remedies coming up, and then say, I might try
this.
Dr. B – There has
been an increase in the number of homeopathic medicines. We have
now close to 4000 medicines. Do you think that there is scope for
using that kind of vast information? Most of the homeopaths use
less than 100 remedies in more than 95% cases. Then what is the
role of those other 3500 remedies that we have? What clinical utility
do these new remedies have?
FS - First of all, I think it is important to confirm that there
are polychrests in homeopathy, and they are still there. So, if
someone knows very well the top 100 remedies, he can do a lot. So,
anyone studying homeopathy should be encouraged to master the 100
polychrests first. Secondly, I have to say that I have cases with
remedies which are not polychrests. I have number of cases with
very new remedies that responded in a very spectacular way and where
I had been giving other remedies without success. So, I confess
that it is my experience that some of the new remedies can bring
about an incredible change where other remedies were failing before.
Dr. B – The percentage
of new remedies that stand out as polychrests is very small compared
to the work done by Hahnemann, Hering and others. Why do you think
that newer remedies often do not stand out as polychrests? Do you
think the provings are deficient?
FS - I think there is a problem of availability, that the information
is not easily available. There is a proving in a journal; think
about it. After one month, you forget a bit about it and after six
months you scarcely remember it at all. So, there again, the repertory
comes in as a tool. It can work as a reminder when a special symptom
comes up. And if we can integrate the provings in the repertory,
people may find them more easily. And there will be greater use
of the newer remedies. Whether one of those new remedies will prove
to be a polychrest is difficult to say. Why was Hahnemann lucky?
Hahnemann also proved medicines that did not turn out to big ones.
Magnets for example. Every remedy Hahnemann proved did not turn
out to be a big one but you are right: Arsenicum, Belladonna all
come out to be very big remedies! I think we have the same with
new remedies. Some will prove--like chocolate or diamond--to be
of use repeatedly and others won’t. It’s difficult to
predict.
Dr. B – In the last
30 or 40 years, there has been a resurgence in the interest in writing
new repertories. People were very comfortable using Kent’s
or Boenninghuasen’s repertory. But after the work of Barthel
(Synthetic Repertory), there have been many new repertories –
Combined, Complete, Synthesis, Murphy’s, Repertorium Universale,
etc. Do you see a need for these different repertories, especially
when they rely on the same sources for expansion? Are they giving
the same platform to the community or are they confusing? Is this
race for getting more rubrics, more remedy references and more data
spoiling the data itself?
FS - Yes it is a worry and a concern. I have and my team has always
worked for quality with version 2, 3, 4 and 5. But then as soon
as the book was published with version 5, this tendency has come
up in the community that more is better. People were telling me
…Listen! I don’t care if the remedy is confirmed in
the rubric or not, it should be there to make me think of the remedy,
it should just be there. So far teachers were saying, just put it
there, put it, put it! And when this demand for quantity became
stronger, we had to find a solution and the solution we have found
is in Synthesis 7. We introduced the repertory views. You can look
at Synthesis with all the information and also look at Synthesis
with less but more reliable information. We have at that time given
more stress on adding more information more quickly and you are
right that there was a jump from version 5 to 6 to 7. We have given
more information more quickly but only after we have provided the
homeopathic community with the tool to get rid of the quantity if
they wanted, to look at the Synthesis repertory view like a content
view where only more confirmed, more reliable information is available.
Dr. B - But doesn’t it happen
if you add a particular remedy or rubric to Synthesis which is not
well confirmed, just by being part of such a work, gives the information
a level of credibility/authenticity? People consider it reliable
because it is there in Synthesis.
FS - Yes. That is a danger and I am happy you
ask this question because this is not our purpose. Our purpose is
to be an index, a synthesis of what is happening in the homeopathic
community and to label it in certain way …to label it in a
way, for example, we would indicate whether certain information
is derived from classical provings or any other type of hypothetical
proving. Then people can decide if they want to use that information
or not. The solution is in making the information available as precisely
as possible. The solution can not be in me deciding whether this
information is reliable or not. Because wherever I will draw the
line, there will be some people who will agree and some people who
will disagree. So I'll get killed either way. So the solution is
not to take the authority for this big decision. The only solution
I find is to be as transparent as possible, and that is possible
in Synthesis.
Dr. B - What future do you see for
Synthesis?
FS - Well, the version 9.1 has been released. This is a big leap,
a big achievement, so version 10 is not coming up as soon as next
year. We have to work a little bit further and take some more time
before releasing version 10 because version 10 should be more special,
and so the goals we have for the moment are mostly on the level
of quality. We are collecting lot of information for correcting
certain things like duplicate rubrics and clarifying language issues;
because of the translations, we got a lot of demands for corrections
of certain rubrics and we are having more information from reliable
sources, from old sources which are not yet available in Synthesis.
We are working since long but I don’t think that still all
the knowledge from our classics is in Synthesis.
Dr. B - In Synthesis 9-1 you have added
six works from Boenningahusen and Boger. You are also planning to
add Kenbo to RADAR. What role do you see of such specialized software
as Kenbo with Synthesis and RADAR?
FS – Well! Kenbo
is an approach on how to proceed in the analysis of the case and
offers assistance in how to bridge the gap between the language
of the patient and where you need to go with your prescription,
and so there is the language of the patient and there is this very
big work that my team is doing and Kenbo will be using that to lead
the practitioner in a more easy way towards the conclusion.
Dr. B - With version 9.1, you have
generalized the rubrics a bit, like you have been bringing the sensations
down and taking the locations up. Kenbo is based on Boenninghausen’s
work and you are also generalizing a bit. Do you think there is
a similarity in the work and if both can merge on a single software
platform.
FS - We have to work on the details and it is our goal to find
the best possible solution for the homeopathic community as a whole.
Dr. B - What in your view is the future
of repertory in general? With thousands of new remedies being proved,
do you think that the repertory will grow to an unmanageable level
in the future?
FS - I don’t think so. The repertory will become more and
more an index, a starting point to go somewhere, the starting point
to go to material medica, like you look at a certain rubric and
see that both Pulsatilla and Nux are jealous and I wonder what is
the difference, and then jump off from the repertory rubric to investigate
the jealousy of Nux and jealousy of Pulsatilla. If I see a small
rubric and see that it is from the proving, I will move to the proving.
I may see an unexpected remedy in a rubric and I see that it is
from a case and I will move to the case. So the repertory will evolve
like an index, a starting point to go to the source information.
Dr. B - But as the number of medicines
grow, rubrics will become larger. If rubrics have 300, 400 remedies
listed against them, do you think they will remain at all useful
in our quest to find the simillimum?
FS - Well, if this is one rubric in the whole repertorization
it can be useful because it may highlight a small remedy. The big
rubrics are big, not exactly because they contain big remedies but
also because they contain small remedies. Say you have taken some
another small rubric of that small remedy and that remedy suddenly
pops up because it is also present in your big rubric.
Dr. B - I will come back to the question
of having many modern repertories. Do you think that the international
homeopathic community needs to build a set of standards to create
future repertories because at present everyone seems to be working
on his own ideas, own interpretation of sources, of what is good
and what is bad. Shouldn’t there be some basic standards on
which everyone should work?
FS - Yes, First I would like to state that I and my team are not
working on our own. We are very much involved with the community.
We have hundreds of people who are collaborating with us and we
let ourselves be influenced by whatever the people are requesting
and saying. We have exchanges in many ways. It is a question of
standards. They will be set mostly in a way that they did not exclude
each other. If I can give the example of quality and quantity, what
has to be the standard? It’s like ten years back this was
a major issue. Whether we stay with quality and we see some other
repertories jumping in numbers or do we add more quantity as well.
The solution is choosing between 2 standards – quality and
quantity. In evolving a technology where both were possible. I believe
again that we must mention the technology or way. Different things
are possible at the same time.
Dr. B - You have written a couple
of books also. Is there any other work that you are working on at
present?
FS - No my focus is still on the repertory. I feel there is still
too much to be done on the repertory to increase the quality, to
streamline the information, to make information more easily available.
So I think for the next few years I will focus on the repertory
until I feel that it has reached a certain point, then I may imagine
other things but at present my focus is very much ion the repertory.
Dr. B – One last question
Frederik. Compiling a repertory like Syntheis is really a big work.
How does your family cope with your busy schedule?
FS – Well! Every day is not as happy as
the other day, if you understand what I mean. I can tell you when
the deadline is there, and we have to fit in with the desktop publishing
team, which has taken 6 weeks to work, the paper has been bought,
the printer has reserved the machines, we can not just stop any
time. So we have to finish in time. So every time we have a deadline
of any version of Synthesis, I can tell you it is a hell of a life.
Dr. B - In general, what future do
you see for homeopathy in the current times?
FS – Well! You know the war is going on
Europe, in US especially and my expectation in fact is that something
will happen that will make this war appear to be very unnecessary.
And that there will be very much greater acceptance of homeopathy
in the Western health care system, like it is already the case in
India. And that homeopathy will be understood to be really very
important, almost first level in health care. This is my expectation.
Dr. B - Thanks you so much Frederick
for this wonderful interview. It was a pleasure to meet you in person
and talk to you in detail.
|